Completed PHASE3 INTERVENTIONAL NCT00002539

Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma

A RANDOMISED TRIAL OF CHEMOTHERAPY WITH OR WITHOUT GRANULOCYTE COLONY-STIMULATING FACTOR IN OPERABLE OSTEOSARCOMA

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Sarcoma

Interventions cisplatin conventional surgery doxorubicin hydrochloride filgrastim

Updated 5 times since 2017 Last updated: Sep 20, 2012 Started: Aug 31, 1993 Primary completion: Oct 31, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Sarcoma, this trial is completed. The trial is conducted by European Organisation for Research and Treatment of Cancer - EORTC and has accumulated 5 data snapshots since 1993. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Aug 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Organisation for Research and Treatment of Cancer - EORTC
Medical Research Council

Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aarhus, Denmark , Amsterdam, Netherlands , Brussels (Bruxelles), Belgium , Copenhagen, Denmark , Edegem, Belgium , Leeds, United Kingdom , Leiden, Netherlands , Leuven, Belgium , Lisbon, Portugal , Ljubljana, Slovenia and 4 more locations